Evidence map›Paper›PMID 37280431›Full record

ArticleBone marrow transplantation2023

Automating outcome analysis after stem cell transplantation: The YORT tool.

Erik G J von Asmuth, Hein Putter, Alexander B Mohseny, Marco W Schilham, John A Snowden, Riccardo Saccardi, Arjan C Lankester

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erik G J von AsmuthDepartment of Pediatrics, Willem Alexander Children's Hospital, Leiden, The Netherlands. e.g.j.von_asmuth@lumc.nl.ORCID 0000-0001-6256-7457
Hein PutterDepartment of Medical Statistics, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0001-5395-1422
Alexander B MohsenyDepartment of Pediatrics, Willem Alexander Children's Hospital, Leiden, The Netherlands.ORCID 0000-0001-7857-4256
Marco W SchilhamDepartment of Pediatrics, Willem Alexander Children's Hospital, Leiden, The Netherlands.ORCID 0000-0003-4391-6003
John A SnowdenDepartment of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.ORCID 0000-0001-6819-3476
Riccardo SaccardiCellular Therapy and Transfusion Medicine, Careggi University Hospital, Firenze, Italy.
Arjan C LankesterDepartment of Pediatrics, Willem Alexander Children's Hospital, Leiden, The Netherlands.ORCID 0000-0002-6703-2993

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cell transplantation is a high-risk procedure. Auditing and yearly outcome reviews help keep optimal quality of care and come with increased survival, but also has significant recurring costs. When data has been entered in a standardized registry, outcome analyses can be automated, which reduces work and increases standardization of performed analyses. To achieve this, we created the Yearly Outcome Review Tool (YORT), an offline, graphical tool that gets data from a single center EBMT registry export, allows the user to define filters and groups, and performs standardized analyses for overall survival, event-free survival, engraftment, relapse rate and non-relapse mortality, complications including acute and chronic Graft vs Host Disease (GvHD), and data completeness. YORT allows users to export data as analyzed to allow you to check data and perform manual analyses. We show the use of this tool on a two-year single-center pediatric cohort, demonstrating how the results for both overall and event-free survival and engraftment can be visualized. The current work demonstrates that using registry data, standardized tools can be made to analyze this data, which allows users to perform outcome reviews for local and accreditation purposes graphically with minimal effort, and help perform detailed standardized analyses. The tool is extensible to be able to accommodate future changes in outcome review and center-specific extensions.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationChildHumansRecurrenceTransplantation Conditioning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.